Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Township, MI
Last reviewed: May 2026
Vasculitis presenting in the feet often looks like a standard petechia rash or ulceration — but it represents systemic vascular inflammation that can indicate lupus, rheumatoid arthritis, cryoglobulinemia, or other conditions requiring immediate rheumatologic workup, not just dermatological treatment. Treating vasculitis lesions as infection delays the systemic diagnosis. Call (810) 206-1402 — foot skin and vascular evaluation in Michigan.
Vasculitis affecting the foot and lower leg produces a characteristic spectrum of cutaneous and ischemic findings that are often first identified by a podiatrist before a systemic diagnosis is established — the lower extremities are the most dependent body part and the first and most severely affected site for small-vessel and medium-vessel vasculitis. The classic presentation is palpable purpura: raised, non-blanching, purple-to-red lesions on the lower leg and dorsum of the foot that represent extravasation of red blood cells from inflamed vessel walls. However, vasculitis can also present as livedo reticularis, painful ulcers, digital ischemia, gangrenous toe changes, subcutaneous nodules, or peripheral neuropathy — and distinguishing these from other vascular, infectious, or inflammatory conditions requires systematic clinical and laboratory evaluation with specialist coordination.
Vasculitis Types Affecting the Foot: Classification, Vessel Size, and Presentation
| Vasculitis Type | Vessel Size | Foot/Lower Leg Presentation | Key Associated Features | Diagnostic Test |
|---|---|---|---|---|
| IgA vasculitis (Henoch-Schonlein Purpura) | Small vessel (capillaries, venules) | Palpable purpura on lower legs and dorsal feet; typically bilateral; may progress to ecchymoses; painful in adults | Children and young adults; arthralgias; abdominal pain; hematuria; follows upper respiratory infection; IgA deposits on biopsy | Skin biopsy showing IgA deposits; urinalysis for hematuria; IgA level; complement levels |
| Hypersensitivity vasculitis (leukocytoclastic) | Small vessel (post-capillary venules) | Palpable purpura lower legs; bilateral; erythematous papules coalescing; may ulcerate in severe cases; symmetric distribution | Drug-induced (NSAIDs, antibiotics, diuretics most common); infection-triggered; idiopathic; self-limited if trigger removed | Skin biopsy (leukocytoclasis = neutrophil nuclear dust); drug history review; cryoglobulins; hepatitis B/C serology |
| Cryoglobulinemic vasculitis | Small vessel | Palpable purpura; livedo reticularis; Raynaud phenomenon; painful ulcers; peripheral neuropathy with burning/numbness in feet | Hepatitis C (type II cryoglobulinemia); multiple myeloma, lymphoma (type I); cold exposure exacerbates; arthralgias; renal involvement | Cryoglobulin serum test (keep sample warm); hepatitis C RNA; complement (low C4 in type II); SPEP |
| Polyarteritis nodosa (PAN) | Medium vessel (muscular arteries) | Livedo reticularis; subcutaneous nodules; digital ischemia; foot/ankle ulcers; mononeuritis multiplex causing foot drop; rarely palpable purpura | Middle-aged adults; hypertension; renal involvement; hepatitis B association; weight loss; fever | Skin/nerve biopsy; arteriography showing microaneurysms; ANCA typically negative; hepatitis B serology |
| ANCA-associated vasculitis (GPA, MPA, EGPA) | Small and medium vessel | Palpable purpura; splinter hemorrhages; nail fold infarcts; digital ischemia; peripheral neuropathy; foot ulcers in severe disease | GPA: upper/lower respiratory tract granulomas; nasal destruction. MPA: rapidly progressive glomerulonephritis. EGPA: asthma, eosinophilia, peripheral neuropathy | ANCA (PR3 for GPA, MPO for MPA/EGPA); renal biopsy; chest imaging; CBC for eosinophilia (EGPA) |
| Buerger disease (thromboangiitis obliterans) | Small and medium vessel (inflammatory thrombosis) | Digital ischemia; rest pain in toes; gangrene of digits; superficial phlebitis; Raynaud phenomenon; severe ischemic ulcers in young smokers | Young male smokers (<45 years) exclusively; no atherosclerosis risk factors; complete tobacco cessation required for any benefit | Clinical diagnosis; arteriography showing corkscrew collaterals; no ANCA; no atherosclerosis; tobacco use confirmed |
Lower Extremity Vasculitis: Clinical Assessment and Management Framework
| Step | Action | Rationale |
|---|---|---|
| History | Drug history (new medications 1-3 weeks before onset); recent infection; systemic symptoms (fever, weight loss, arthralgias, abdominal pain); smoking history; hepatitis exposure; family history of autoimmune disease | Drug-induced and infection-triggered vasculitis are most common — identifying and removing the trigger is the primary treatment; systemic features direct workup |
| Skin biopsy | Punch biopsy of fresh purpuric lesion (<24 hours old preferred); H&E, direct immunofluorescence (DIF), and culture; biopsy edge of ulcer if present | Biopsy is essential for definitive diagnosis; DIF distinguishes IgA vasculitis from other types; culture excludes infectious mimics |
| Laboratory workup | CBC with differential; CMP (renal function); urinalysis with microscopy (RBC casts = renal involvement); ESR, CRP; ANCA panel; ANA; complement (C3, C4); cryoglobulins; hepatitis B and C serology; HIV; SPEP | Abnormal urinalysis suggests systemic vasculitis requiring rheumatology urgently; hepatitis serology essential for treatment planning |
| Wound care | Non-adherent dressings; moisture-retentive environment; avoid compression if arterial involvement; offloading; conservative debridement only of clearly infected necrotic tissue | Vasculitic ulcers are ischemic in origin — aggressive debridement without addressing underlying vasculitis does not promote healing |
| Treatment principles | Remove triggers (drugs, infections); oral prednisone for moderate-severe vasculitis; cyclophosphamide or rituximab for ANCA-associated; hepatitis C treatment for cryoglobulinemia; smoking cessation mandatory for Buerger; rheumatology co-management | Treatment is systemic and etiology-specific — podiatric wound management alone is insufficient; systemic immunosuppression or trigger removal is required for disease control |
| Referral criteria | Immediate rheumatology referral for: suspected systemic vasculitis; abnormal renal function; ANCA positivity; hematuria on urinalysis; any vasculitis with organ involvement beyond skin | Systemic vasculitis with renal involvement can progress to renal failure rapidly — rheumatology involvement within days is appropriate |
At Balance Foot & Ankle in Howell and Bloomfield Township, lower extremity palpable purpura or unexplained painful ulcers in patients without clear vascular disease triggers a vasculitis workup — skin biopsy, urinalysis with microscopy, ANCA panel, and hepatitis serology — with rheumatology coordination when systemic involvement is identified. Call (810) 206-1402.
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Township, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Doctor Answer
What are the symptoms of vasculitis affecting the feet?
Vasculitis affecting the feet causes inflammation of blood vessels, resulting in palpable purpura (raised red-purple spots), skin ulcers, livedo reticularis, ischemic toes, and in severe cases digital gangrene. It can be triggered by infections, medications, or systemic autoimmune disease and requires medical workup for underlying cause. Dr. Tom Biernacki at Balance Foot & Ankle recognizes the foot manifestations of vasculitis and coordinates prompt medical referral while managing the local wound and skin complications.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.
More questions patients ask
What are the signs of vasculitis in the feet?
Vasculitis in the feet presents as: palpable purpura (non-blanching purple or red spots that feel raised), livedo reticularis (net-like bluish skin mottling), cutaneous ulcers (especially over the malleoli and dorsum), digital gangrene (in small-vessel vasculitis), and skin nodules. These findings represent inflammation of blood vessel walls causing vessel wall damage and tissue ischemia. Any non-blanching rash on the foot warrants urgent evaluation.
What causes vasculitis in the feet?
Systemic vasculitis causes: rheumatoid arthritis, systemic lupus erythematosus, ANCA-associated vasculitis (GPA, MPA), cryoglobulinemia, polyarteritis nodosa, IgA vasculitis (Henoch-Schönlein purpura). Secondary causes: medication reactions, infections (hepatitis B, hepatitis C, HIV). The cause determines treatment — immunosuppression is needed for autoimmune vasculitis; antibiotics for infectious vasculitis; drug withdrawal for drug-induced cases.
How is vasculitis in the feet treated?
Treatment depends on the underlying cause. Autoimmune vasculitis: systemic corticosteroids, often with steroid-sparing agents (methotrexate, azathioprine, rituximab). Local wound care for ulcers; vasodilators for Raynaud's-associated vasospasm. Referral to rheumatology is essential for systemic vasculitis — foot manifestations are often the first sign of a treatable systemic disease. Podiatric management focuses on wound care and protecting ischemic tissue while systemic treatment is initiated.
Still have a question about coverage or cost? Book online and we will check your benefits before your visit: Book in Howell · Book in Bloomfield Township. Prefer to talk it through first? Call (810) 206-1402.